Frequent mutation of histone modifying genes in non-Hodgkin lymphoma

Follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) are the two most common non-Hodgkin lymphomas (NHLs). Here we sequenced tumour and matched normal DNA from 13 DLBCL cases and one FL case to identify genes with mutations in B-cell NHL. We analysed RNA-seq data from these and another 113 NHLs to identify genes with candidate mutations, and then re-sequenced tumour and matched normal DNA from these cases to confirm 109 genes with multiple somatic mutations. Genes with roles in histone modification were frequent targets of somatic mutation. For example, 32% of DLBCL and 89% of FL cases had somatic mutations in MLL2, which encodes a histone methyltransferase, and 11.4% and 13.4% of DLBCL and FL cases, respectively, had mutations in MEF2B, a calcium-regulated gene that cooperates with CREBBP and EP300 in acetylating histones. Our analysis suggests a previously unappreciated disruption of chromatin biology in lymphomagenesis.

• Publication year

  2011

• Venue

  Nature

• Publication date

  2011-07-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature10351PMID 21796119PMCID 3210554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Genetic Landscape of the Childhood Cancer Medulloblastoma

  2011cited by this paper
• Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation.

  2011cited by this paper
• Oncogenically active MYD88 mutations in human lymphoma

  2011cited by this paper
• Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly

  2011cited by this paper
• Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase

  2011cited by this paper
• Inactivating mutations of acetyltransferase genes in B-cell lymphoma

  2010cited by this paper
• Somatic mutation of EZH2 (Y641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal Center Origin

  2010cited by this paper
• Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

  2010cited by this paper
• SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors

  2010cited by this paper
• De novo assembly and analysis of RNA-seq data

  2010cited by this paper
• Cancer esearch cular and Cellular Pathobiology uired TNFRSF 14 Mutations in Follicular Lymphoma Are R ociated with Worse Prognosis

  2010cited by this paper
• Aggressive lymphomas.

  2010cited by this paper
• Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes

  2010cited by this paper
• Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

  2010cited by this paper
• Global Analysis of H3K4 Methylation Defines MLL Family Member Targets and Points to a Role for MLL1-Mediated H3K4 Methylation in the Regulation of Transcriptional Initiation by RNA Polymerase II

  2009cited by this paper
• Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

  2009cited by this paper
• Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma

  2009cited by this paper
• Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

  2009cited by this paper
• Frequent inactivation of A20 in B-cell lymphomas

  2009cited by this paper
• SGK1 Phosphorylation of IκB Kinase α and p300 Up-regulates NF-κB Activity and Increases N-Methyl-D-aspartate Receptor NR2A and NR2B Expression*

  2009cited by this paper
• Recurring mutations found by sequencing an acute myeloid leukemia genome.

  2009cited by this paper
• BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma

  2009cited by this paper
• A small cell lung cancer genome reports complex tobacco exposure signatures

  2009cited by this paper
• Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation.

  2008cited by this paper
• Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

  2008cited by this paper
• Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

  2008influential reference
• Mapping and quantifying mammalian transcriptomes by RNA-Seq

  2008cited by this paper
• Clinical Trials and Observations

  2008cited by this paper
• Distinct regions of Galpha13 participate in its regulatory interactions with RGS homology domain-containing RhoGEFs.

  2007cited by this paper
• Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma

  2007cited by this paper
• Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer

  2006cited by this paper
• Knockdown of ALR (MLL2) Reveals ALR Target Genes and Leads to Alterations in Cell Adhesion and Growth

  2006cited by this paper
• Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

  2006cited by this paper
• BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma.

  2004cited by this paper
• Optimal B-cell proliferation requires phosphoinositide 3-kinase-dependent inactivation of FOXO transcription factors.

  2004cited by this paper
• ALL-1/MLL1, a homologue of Drosophila TRITHORAX, modifies chromatin and is directly involved in infant acute leukaemia

  2004cited by this paper
• A census of human cancer genes

  2004cited by this paper
• Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2.

  2004cited by this paper
• Protein Kinase A-mediated Phosphorylation of the Gα13 Switch I Region Alters the Gαβγ13-G Protein-coupled Receptor Complex and Inhibits Rho Activation*

  2003cited by this paper
• Protein kinase A-mediated phosphorylation of the Galpha13 switch I region alters the Galphabetagamma13-G protein-coupled receptor complex and inhibits Rho activation.

  2003cited by this paper
• A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

  2003cited by this paper
• Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes

  2003cited by this paper
• MLL targets SET domain methyltransferase activity to Hox gene promoters.

  2002cited by this paper
• Protein Kinase SGK Mediates Survival Signals by Phosphorylating the Forkhead Transcription Factor FKHRL1 (FOXO3a)

  2001cited by this paper
• Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2.

  2000cited by this paper
• BCL10 gene mutation in lymphoma.

  2000cited by this paper
• Gα13 Requires Palmitoylation for Plasma Membrane Localization, Rho-dependent Signaling, and Promotion of p115-RhoGEF Membrane Binding*

  2000cited by this paper
• p300 and CBP: Partners for life and death

  1999cited by this paper
• Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project.

  1998cited by this paper
• Hox genes in vertebrate development.

  1994cited by this paper
• BIOINFORMATICS ORIGINAL PAPER

  year unknowncited by this paper

• The impact of clinical manifestations on the prognosis of diffuse large B-cell lymphoma

  2026cites this paper
• A rare diffuse follicular lymphoma with TP53 mutation and copy-neutral loss of heterozygosity at 1p36: insights into diagnosis, disease progression, and literature review

  2026cites this paper
• Surveillance Strategies in Follicular Non-Hodgkin's Lymphoma's Using Molecular and Genetic Markers Improve Cost-efficiencies Over Routine Imaging Studies.

  2026cites this paper
• Epigenetic dysregulation of B-cells in autoimmune diseases and lymphomas (Review)

  2026cites this paper
• Discordant lymphoma consisting of splenic marginal zone lymphoma and diffuse large B-cell lymphoma in a hepatitis B virus carrier suggests virus-associated lymphomagenesis.

  2026cites this paper
• Gene Methylation Profile in Hematologic Malignancies

  2026cites this paper
• Multifaceted roles of CRISPR technology in blood cancer research.

  2025cites this paper
• Targeted Degradation of Class 1 HDACs With PROTACs is Highly Effective at Inducing DLBCL Cell Death

  2025cites this paper
• Role of mutational signatures and clonality assessments in tailoring targeted therapies for lymphoma

  2025cites this paper
• The Overexpression of Collagen Receptor DDR1 is Associated With Chromosome Instability and Aneuploidy in Diffuse Large B‐Cell Lymphoma

  2025influential citation
• C3G deregulation uncovers a dual role in B-cell lymphoma: tumor suppression and enhanced metastasis via Rap1 and Rac2 signaling

  2025cites this paper
• Developmental stage and cellular context determine oncogenic and molecular outcomes of Ezh2Y641F mutation in hematopoiesis

  2025cites this paper
• Chromatin Regulatory Targets for Anticancer Therapeutics.

  2025cites this paper
• Beware the zombie enzyme.

  2025cites this paper
• Polycomb repressive complex 2 (PRC2) pathway’s role in cancer cell plasticity and drug resistance

  2025cites this paper
• Single-Agent and Associated Therapies with Monoclonal Antibodies: What About Follicular Lymphoma?

  2025cites this paper
• Recent advances in understanding of pathogenesis and treatment development for diffuse large B-cell lymphoma and follicular lymphoma

  2025cites this paper
• Establishment of Two Novel Ovarian Tumor Cell Lines with Characteristics of Mucinous Borderline Tumors or Dedifferentiated Carcinoma—Implications for Tumor Heterogeneity and the Complex Carcinogenesis of Mucinous Tumors

  2025cites this paper
• Distinct genetic alterations in CD10-negative MUM1-positive follicular lymphoma.

  2025cites this paper
• Histone-Lysine N-Methyltransferase 2D (KMT2D) Impending Therapeutic Target for the Management of Cancer: The Giant Rats Tail.

  2025cites this paper
• Dynamic change in Epstein-Barr virus DNA predicts prognosis in early stage natural killer/T-cell lymphoma with pegaspargase-based treatment: long-term follow-up and biomarker analysis from the NHL-004 multicenter randomized study

  2025cites this paper
• Advances in Personalized Treatment and Prognostic Factors of Follicular Lymphoma

  2025cites this paper
• IRF4 promotes immune evasion and shapes the tumor microenvironment in Follicular Lymphoma.

  2025cites this paper
• Genetic Subtype‐Based International Prognostic Index Prognostic Model in Diffuse Large B‐Cell Lymphoma

  2025cites this paper
• Integrated genomics with refined cell-of-origin subtyping distinguishes subtype-specific mechanisms of treatment resistance and relapse in diffuse large B-cell lymphoma

  2025cites this paper
• Nanopore Sequencing Reveals Novel Alternative Splice Variants of EZH2 in Pediatric Medulloblastoma

  2025cites this paper
• Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma

  2025cites this paper
• miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response

  2025cites this paper
• An epigenetic pathway regulates MHC-II expression and function in B cell lymphoma models

  2025cites this paper
• Epigenetically programmed identity crisis to combat diffuse large B cell lymphoma.

  2025cites this paper
• Chidamide: Exploration of maintenance therapy for patients with DLBCL with HBV infection

  2025cites this paper
• TET enzymes: Involvement in cancer development and therapeutical perspectives.

  2025cites this paper
• DLBCLone: A unified framework for neighbourhood-based genetic subtyping of lymphomas

  2025cites this paper
• TP53 mutation and immunohistochemical p53 expression characteristics in diffuse large B–cell lymphoma

  2025cites this paper
• Molekular zielgerichtete Therapien – brauchen wir überhaupt noch Chemotherapie?

  2025cites this paper
• Inference of gene coexpression networks from single-cell transcriptome data based on variance decomposition analysis

  2025cites this paper
• Age‐ and gender‐specific molecular characteristics of diffuse large B‐cell lymphoma: Results from clinical trials of the DSHNHL/GLA

  2025cites this paper
• Audit of B-cell cancer genes

  2025cites this paper
• Investigation of MRI features in subtypes of primary central nervous system diffuse large B-cell lymphoma

  2025cites this paper
• STAT6 mutations compensate for CREBBP mutations and hyperactivate IL4/STAT6/RRAGD/mTOR signaling in follicular lymphoma

  2025cites this paper
• Acute chromatin decompaction stiffens the nucleus as revealed by nanopillar-induced nuclear deformation in cells

  2025cites this paper
• Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics.

  2025cites this paper
• Detecting Somatic Mutations in Rare Clones using Single Cell Multi-Omics

  2025cites this paper
• Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers

  2025cites this paper
• Circulating tumor DNA in lymphoma: technologies and applications

  2025cites this paper
• The Supportive Role of Lymph Node Mesenchymal Stromal Cells in Follicular Lymphoma Involves the PITX1–hTERT–Podoplanin Axis

  2025cites this paper
• B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.

  2025cites this paper
• Canonical and Non‐Canonical Functions of Histone H3K4 Methylation Modifiers in Cancer

  2025cites this paper
• B-cell non-Hodgkin lymphomas.

  2024cites this paper
• Mutational synergy with CREBBP loss in lymphomagenesis identified through forward insertional mutagenesis in a new DLBCL mouse model

  2024cites this paper
• Mutant FOXO1 controls an oncogenic network via enhancer accessibility

  2024cites this paper
• Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement

  2024cites this paper
• Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments

  2024cites this paper
• Targeting kelch-like (KLHL) proteins: achievements, challenges and perspectives.

  2024cites this paper
• FOXO1 promotes cancer cell growth through MDM2-mediated p53 degradation

  2024cites this paper
• Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics

  2024influential citation
• The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer

  2024cites this paper
• ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis.

  2024cites this paper
• Genetic mechanisms underlying tumor microenvironment composition and function in diffuse large B cell lymphoma.

  2024cites this paper
• Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma

  2024cites this paper
• Multisite clinical cross-validation and variant interpretation of a next generation sequencing panel for lymphoid cancer prognostication

  2024cites this paper
• Molecular Features of HHV8 Monoclonal Microlymphoma Associated with Kaposi Sarcoma and Multicentric Castleman Disease in an HIV-Negative Patient

  2024cites this paper
• Mapping in silico genetic networks of the KMT2D tumour suppressor gene to uncover novel functional associations and cancer cell vulnerabilities

  2024cites this paper
• Follicular lymphoma presenting with symptomatic bone involvement: a clinicopathological and molecular analysis of 16 cases.

  2024cites this paper
• Anlotinib suppresses the DNA damage response by disrupting SETD1A and inducing p53-dependent apoptosis in Transformed Follicular Lymphoma

  2024cites this paper
• The Oncogenic Lipid Sphingosine-1-Phosphate Impedes the Phagocytosis of Tumor Cells by M1 Macrophages in Diffuse Large B Cell Lymphoma

  2024influential citation
• Mutant mice lacking alternatively spliced p53 isoforms unveil Ackr4 as a male-specific prognostic factor in Myc-driven B-cell lymphomas

  2024cites this paper
• MEF2D facilitates liver metastasis of gastric cancer cells through directly inducing H1X under IL-13 stimulation.

  2024cites this paper
• Dysregulation of the p300/CBP histone acetyltransferases in human cancer.

  2024cites this paper
• Artificial Intelligence-Driven Precision Medicine: Multi-Omics and Spatial Multi-Omics Approaches in Diffuse Large B-Cell Lymphoma (DLBCL).

  2024cites this paper
• Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening

  2024cites this paper
• Bispecific antibodies for the treatment of hematologic malignancies: The magic is T-cell redirection.

  2024cites this paper
• Clinical and splenectomy-based treatment outcomes in 40 cases of hepatosplenic T-cell lymphoma: a comprehensive analysis

  2024cites this paper
• Genomic landscape and molecular subtypes of primary central nervous system lymphoma

  2024cites this paper
• The Epigenetic Hallmarks of Cancer.

  2024cites this paper
• The clinical utility of plasma circulating tumor DNA in the diagnosis and disease surveillance in non-diffuse large B-cell non-Hodgkin lymphomas.

  2024cites this paper
• Follicular lymphoma research: an open dialogue for a collaborative roadmap

  2024cites this paper
• Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study

  2024cites this paper
• Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma

  2024cites this paper
• Histone lysine methylation modifiers controlled by protein stability

  2024cites this paper
• MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis

  2024cites this paper
• Regulation of B-cell function by miRNAs impacting Systemic lupus erythematosus progression.

  2024cites this paper
• Unraveling the role of cancer-associated fibroblasts in B cell lymphoma

  2024cites this paper
• Developmental Stage and Cellular Context Determine Oncogenic and Molecular Outcomes of Ezh2Y641F Mutation in Hematopoiesis

  2024cites this paper
• The POD24 challenge: where do we go from here for early progressors?

  2024cites this paper
• Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies

  2024cites this paper
• SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma

  2024cites this paper
• Current and future therapies for follicular lymphoma

  2024cites this paper
• GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma

  2024cites this paper
• Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes

  2024cites this paper
• Epigenetic-modifying agents: the potential game changers in the treatment of hematologic malignancies.

  2024cites this paper
• Silencing GNAS enhances HDAC3i efficacy in CREBBP wild type B cell lymphoma

  2024cites this paper
• Plasma circulating tumour DNA is a better source for diagnosis and mutational analysis of IVLBCL than tissue DNA

  2024cites this paper
• ETS1 Function in Leukemia and Lymphoma.

  2024cites this paper
• Advances in biology, diagnosis and treatment of DLBCL

  2024cites this paper
• The histone methyltransferase KMT2D maintains cellular glucocorticoid responsiveness by shielding the glucocorticoid receptor from degradation

  2024cites this paper
• Insights into the mechanisms driven by H3K4 KMTs in pancreatic cancer.

  2024cites this paper
• Advances in CRISPR-Cas systems for blood cancer.

  2024cites this paper
• Research Progress of Application of Zebutinib in the Clinical Treatment of Diffuse Large B-Cell Lymphoma

  2024cites this paper
• Determinants of Chromatin Organization in Aging and Cancer—Emerging Opportunities for Epigenetic Therapies and AI Technology

  2024cites this paper